Adherium Limited (ADR.AX)
AUD 0.01
(9.09%)
AUD 0.01
(9.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -10.22 Million AUD | -3.71% |
| 2023 | -9.85 Million AUD | 1.85% |
| 2022 | -10.04 Million AUD | 33.2% |
| 2021 | -15.03 Million AUD | -31.93% |
| 2020 | -11.39 Million AUD | 3.37% |
| 2019 | -11.79 Million AUD | -26.3% |
| 2018 | -9.33 Million AUD | 27.1% |
| 2017 | -12.81 Million AUD | -103.08% |
| 2016 | -6.3 Million AUD | -402.63% |
| 2015 | -1.25 Million AUD | 43.13% |
| 2014 | -2.2 Million AUD | -1493.37% |
| 2013 | -138.5 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -10.22 Million AUD | -3.71% |
| 2024 Q4 | -5.54 Million AUD | 0.0% |
| 2024 Q2 | -4.67 Million AUD | 0.0% |
| 2023 FY | -9.85 Million AUD | 1.85% |
| 2023 Q4 | -4.03 Million AUD | 0.0% |
| 2023 Q2 | -5.82 Million AUD | 0.0% |
| 2022 Q4 | -4.98 Million AUD | 0.0% |
| 2022 FY | -10.04 Million AUD | 33.2% |
| 2022 Q2 | -5.05 Million AUD | 0.0% |
| 2021 Q2 | -8.57 Million AUD | 0.0% |
| 2021 Q4 | -6.45 Million AUD | 0.0% |
| 2021 FY | -15.03 Million AUD | -31.93% |
| 2020 Q2 | -4.48 Million AUD | 0.0% |
| 2020 Q4 | -6.91 Million AUD | 0.0% |
| 2020 FY | -11.39 Million AUD | 3.37% |
| 2019 FY | -11.79 Million AUD | -26.3% |
| 2019 Q4 | -3.14 Million AUD | 0.0% |
| 2019 Q2 | -8.64 Million AUD | 0.0% |
| 2018 Q4 | -4.36 Million AUD | 0.0% |
| 2018 Q2 | -4.97 Million AUD | 0.0% |
| 2018 FY | -9.33 Million AUD | 27.1% |
| 2017 Q2 | -4.8 Million AUD | 0.0% |
| 2017 FY | -12.81 Million AUD | -103.08% |
| 2017 Q4 | -8 Million AUD | 0.0% |
| 2016 FY | -6.3 Million AUD | -402.63% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 FY | -1.25 Million AUD | 43.13% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | -2.2 Million AUD | -1493.37% |
| 2013 FY | -138.5 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 71.583% |
| Aroa Biosurgery Limited | -9.74 Million AUD | -4.882% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -49.306% |
| Anteris Technologies Ltd | -67.33 Million AUD | 84.816% |
| Control Bionics Limited | -5.91 Million AUD | -72.887% |
| CardieX Limited | -6.76 Million AUD | -51.125% |
| Compumedics Limited | -338 Thousand AUD | -2924.903% |
| Cochlear Limited | 356.8 Million AUD | 102.866% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -226.95% |
| Cyclopharm Limited | -4.7 Million AUD | -117.498% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -274.565% |
| Nova Eye Medical Limited | -8.79 Million AUD | -16.316% |
| HeraMED Limited | -6.78 Million AUD | -50.717% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 54.812% |
| ImpediMed Limited | -19.79 Million AUD | 48.337% |
| InhaleRx Limited | -1.44 Million AUD | -608.403% |
| LBT Innovations Limited | -3.74 Million AUD | -173.374% |
| Micro-X Limited | -9.76 Million AUD | -4.702% |
| Neurotech International Limited | -5.06 Million AUD | -101.69% |
| OncoSil Medical Limited | -11.91 Million AUD | 14.181% |
| PolyNovo Limited | 5.26 Million AUD | 294.339% |
| Respiri Limited | -7.12 Million AUD | -43.412% |
| SomnoMed Limited | -12.24 Million AUD | 16.481% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -51.659% |
| Uscom Limited | -2.07 Million AUD | -392.791% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -101.927% |